chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, Blood immunoglobulin M normal, Body temperature increased, Brain natriuretic peptide increased
Clinical narrative: This case was received on 27 May 2011 from MILVAX under the MILVAX tracking number FDA-14 (no VAERS). An obese male patient (age not reported) received in 2011 the ACAM2000 (lot number and exact date not reported) and 10 days post vaccination experienced chills, diaphoresis and crushing/squeezing tight sub-sternal chest pain that increased with exertion and worsened on inspiration. The chest pain was not fully relieved with rest 8/10 scale and increased when lying down. The patient had 4-5 day prodromal history of malaise, fatigue, increased sleep and mild upper respiratory signs and symptoms prior to chest pain. Laboratory and diagnostic test 10 days post vaccination included: CK 613 and 705; CKMB 22; Troponin 1 1.12 and 30.09; abnormal 20:20; WBC 17.25; PT 13.0; ECG normal: no ST elevation or decrease, no bundle branch block and no T-wave inversions; Chest X-ray: no pneumonia, pneumothorax or cardiomegaly. Assessment plan 10 days post vaccination reports "due to increased Troponin, chest pain with normal ECG likely the patient is suffering from myocarditis however, cardiac thrombosis and MI are part of the differential diagnosis and require further work up." The patient was transferred to the hospital. On 11 days post vaccination, cardiac CT (computerized tomography) and ECHO demonstrated slightly reduced LV EF of 55%. The patient's temperature increased to 104 degrees. On 12 days post vaccination, the patient's chest pain was down to 3/10 scale and only on inspiration. Troponin levels were 1 to 3 to 3.7 to 12.4 to 9.04 to 14.0 to 7.8. On 14 days post vaccination, laboratory results included: Brain Natriuretic Peptide-B type 166, C Reactive Protein 2.4. The patient was discharged from the hospital on day 14 post vaccination after Troponin I levels decreased with no further chest pain or ECG changes. Follow-up appointment on day 15 post vaccination patient had no complaints, no fever and no signs or symptoms. He was treated with IBUPROFEN for one month. On 35 days post vaccination, "extensive labs were completed to discover an alternative cause for diagnosis." The only notable result was for a + Dengue IgG, which is of unclear significance given his negative IgM. The patient's final diagnosis was vaccine related myocarditis. The outcome was not reported. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL
Symptoms: C-reactive protein increased, Chest X-ray normal, Chest pain, Chills, Computerised tomogram abnormal
Clinical narrative: This case was received on 27 May 2011 from MILVAX under the MILVAX tracking number FDA-14 (no VAERS). An obese male patient (age not reported) received in 2011 the ACAM2000 (lot number and exact date not reported) and 10 days post vaccination experienced chills, diaphoresis and crushing/squeezing tight sub-sternal chest pain that increased with exertion and worsened on inspiration. The chest pain was not fully relieved with rest 8/10 scale and increased when lying down. The patient had 4-5 day prodromal history of malaise, fatigue, increased sleep and mild upper respiratory signs and symptoms prior to chest pain. Laboratory and diagnostic test 10 days post vaccination included: CK 613 and 705; CKMB 22; Troponin 1 1.12 and 30.09; abnormal 20:20; WBC 17.25; PT 13.0; ECG normal: no ST elevation or decrease, no bundle branch block and no T-wave inversions; Chest X-ray: no pneumonia, pneumothorax or cardiomegaly. Assessment plan 10 days post vaccination reports "due to increased Troponin, chest pain with normal ECG likely the patient is suffering from myocarditis however, cardiac thrombosis and MI are part of the differential diagnosis and require further work up." The patient was transferred to the hospital. On 11 days post vaccination, cardiac CT (computerized tomography) and ECHO demonstrated slightly reduced LV EF of 55%. The patient's temperature increased to 104 degrees. On 12 days post vaccination, the patient's chest pain was down to 3/10 scale and only on inspiration. Troponin levels were 1 to 3 to 3.7 to 12.4 to 9.04 to 14.0 to 7.8. On 14 days post vaccination, laboratory results included: Brain Natriuretic Peptide-B type 166, C Reactive Protein 2.4. The patient was discharged from the hospital on day 14 post vaccination after Troponin I levels decreased with no further chest pain or ECG changes. Follow-up appointment on day 15 post vaccination patient had no complaints, no fever and no signs or symptoms. He was treated with IBUPROFEN for one month. On 35 days post vaccination, "extensive labs were completed to discover an alternative cause for diagnosis." The only notable result was for a + Dengue IgG, which is of unclear significance given his negative IgM. The patient's final diagnosis was vaccine related myocarditis. The outcome was not reported. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram normal, Fatigue, Flavivirus test positive
Clinical narrative: This case was received on 27 May 2011 from MILVAX under the MILVAX tracking number FDA-14 (no VAERS). An obese male patient (age not reported) received in 2011 the ACAM2000 (lot number and exact date not reported) and 10 days post vaccination experienced chills, diaphoresis and crushing/squeezing tight sub-sternal chest pain that increased with exertion and worsened on inspiration. The chest pain was not fully relieved with rest 8/10 scale and increased when lying down. The patient had 4-5 day prodromal history of malaise, fatigue, increased sleep and mild upper respiratory signs and symptoms prior to chest pain. Laboratory and diagnostic test 10 days post vaccination included: CK 613 and 705; CKMB 22; Troponin 1 1.12 and 30.09; abnormal 20:20; WBC 17.25; PT 13.0; ECG normal: no ST elevation or decrease, no bundle branch block and no T-wave inversions; Chest X-ray: no pneumonia, pneumothorax or cardiomegaly. Assessment plan 10 days post vaccination reports "due to increased Troponin, chest pain with normal ECG likely the patient is suffering from myocarditis however, cardiac thrombosis and MI are part of the differential diagnosis and require further work up." The patient was transferred to the hospital. On 11 days post vaccination, cardiac CT (computerized tomography) and ECHO demonstrated slightly reduced LV EF of 55%. The patient's temperature increased to 104 degrees. On 12 days post vaccination, the patient's chest pain was down to 3/10 scale and only on inspiration. Troponin levels were 1 to 3 to 3.7 to 12.4 to 9.04 to 14.0 to 7.8. On 14 days post vaccination, laboratory results included: Brain Natriuretic Peptide-B type 166, C Reactive Protein 2.4. The patient was discharged from the hospital on day 14 post vaccination after Troponin I levels decreased with no further chest pain or ECG changes. Follow-up appointment on day 15 post vaccination patient had no complaints, no fever and no signs or symptoms. He was treated with IBUPROFEN for one month. On 35 days post vaccination, "extensive labs were completed to discover an alternative cause for diagnosis." The only notable result was for a + Dengue IgG, which is of unclear significance given his negative IgM. The patient's final diagnosis was vaccine related myocarditis. The outcome was not reported. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Hyperhidrosis, Hypersomnia, Malaise, Myocarditis, Painful respiration
Clinical narrative: This case was received on 27 May 2011 from MILVAX under the MILVAX tracking number FDA-14 (no VAERS). An obese male patient (age not reported) received in 2011 the ACAM2000 (lot number and exact date not reported) and 10 days post vaccination experienced chills, diaphoresis and crushing/squeezing tight sub-sternal chest pain that increased with exertion and worsened on inspiration. The chest pain was not fully relieved with rest 8/10 scale and increased when lying down. The patient had 4-5 day prodromal history of malaise, fatigue, increased sleep and mild upper respiratory signs and symptoms prior to chest pain. Laboratory and diagnostic test 10 days post vaccination included: CK 613 and 705; CKMB 22; Troponin 1 1.12 and 30.09; abnormal 20:20; WBC 17.25; PT 13.0; ECG normal: no ST elevation or decrease, no bundle branch block and no T-wave inversions; Chest X-ray: no pneumonia, pneumothorax or cardiomegaly. Assessment plan 10 days post vaccination reports "due to increased Troponin, chest pain with normal ECG likely the patient is suffering from myocarditis however, cardiac thrombosis and MI are part of the differential diagnosis and require further work up." The patient was transferred to the hospital. On 11 days post vaccination, cardiac CT (computerized tomography) and ECHO demonstrated slightly reduced LV EF of 55%. The patient's temperature increased to 104 degrees. On 12 days post vaccination, the patient's chest pain was down to 3/10 scale and only on inspiration. Troponin levels were 1 to 3 to 3.7 to 12.4 to 9.04 to 14.0 to 7.8. On 14 days post vaccination, laboratory results included: Brain Natriuretic Peptide-B type 166, C Reactive Protein 2.4. The patient was discharged from the hospital on day 14 post vaccination after Troponin I levels decreased with no further chest pain or ECG changes. Follow-up appointment on day 15 post vaccination patient had no complaints, no fever and no signs or symptoms. He was treated with IBUPROFEN for one month. On 35 days post vaccination, "extensive labs were completed to discover an alternative cause for diagnosis." The only notable result was for a + Dengue IgG, which is of unclear significance given his negative IgM. The patient's final diagnosis was vaccine related myocarditis. The outcome was not reported. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Prothrombin time prolonged, Troponin I increased, Troponin increased, Upper respiratory tract infection, White blood cell count increased
Clinical narrative: This case was received on 27 May 2011 from MILVAX under the MILVAX tracking number FDA-14 (no VAERS). An obese male patient (age not reported) received in 2011 the ACAM2000 (lot number and exact date not reported) and 10 days post vaccination experienced chills, diaphoresis and crushing/squeezing tight sub-sternal chest pain that increased with exertion and worsened on inspiration. The chest pain was not fully relieved with rest 8/10 scale and increased when lying down. The patient had 4-5 day prodromal history of malaise, fatigue, increased sleep and mild upper respiratory signs and symptoms prior to chest pain. Laboratory and diagnostic test 10 days post vaccination included: CK 613 and 705; CKMB 22; Troponin 1 1.12 and 30.09; abnormal 20:20; WBC 17.25; PT 13.0; ECG normal: no ST elevation or decrease, no bundle branch block and no T-wave inversions; Chest X-ray: no pneumonia, pneumothorax or cardiomegaly. Assessment plan 10 days post vaccination reports "due to increased Troponin, chest pain with normal ECG likely the patient is suffering from myocarditis however, cardiac thrombosis and MI are part of the differential diagnosis and require further work up." The patient was transferred to the hospital. On 11 days post vaccination, cardiac CT (computerized tomography) and ECHO demonstrated slightly reduced LV EF of 55%. The patient's temperature increased to 104 degrees. On 12 days post vaccination, the patient's chest pain was down to 3/10 scale and only on inspiration. Troponin levels were 1 to 3 to 3.7 to 12.4 to 9.04 to 14.0 to 7.8. On 14 days post vaccination, laboratory results included: Brain Natriuretic Peptide-B type 166, C Reactive Protein 2.4. The patient was discharged from the hospital on day 14 post vaccination after Troponin I levels decreased with no further chest pain or ECG changes. Follow-up appointment on day 15 post vaccination patient had no complaints, no fever and no signs or symptoms. He was treated with IBUPROFEN for one month. On 35 days post vaccination, "extensive labs were completed to discover an alternative cause for diagnosis." The only notable result was for a + Dengue IgG, which is of unclear significance given his negative IgM. The patient's final diagnosis was vaccine related myocarditis. The outcome was not reported. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Echocardiogram abnormal, Electrocardiogram normal, Myocardial infarction, Myocarditis, Troponin I increased
Clinical narrative: This case was received on 27 May 2011 from MILVAX under the MILVAX tracking number FDA-14 (no VAERS). An obese male patient (age not reported) received in 2011 the ACAM2000 (lot number and exact date not reported) and 10 days post vaccination experienced chills, diaphoresis and crushing/squeezing tight sub-sternal chest pain that increased with exertion and worsened on inspiration. The chest pain was not fully relieved with rest 8/10 scale and increased when lying down. The patient had 4-5 day prodromal history of malaise, fatigue, increased sleep and mild upper respiratory signs and symptoms prior to chest pain. Laboratory and diagnostic test 10 days post vaccination included: CK 613 and 705; CKMB 22; Troponin 1 1.12 and 30.09; abnormal 20:20; WBC 17.25; PT 13.0; ECG normal: no ST elevation or decrease, no bundle branch block and no T-wave inversions; Chest X-ray: no pneumonia, pneumothorax or cardiomegaly. Assessment plan 10 days post vaccination reports "due to increased Troponin, chest pain with normal ECG likely the patient is suffering from myocarditis however, cardiac thrombosis and MI are part of the differential diagnosis and require further work up." The patient was transferred to the hospital. On 11 days post vaccination, cardiac CT (computerized tomography) and ECHO demonstrated slightly reduced LV EF of 55%. The patient's temperature increased to 104 degrees. On 12 days post vaccination, the patient's chest pain was down to 3/10 scale and only on inspiration. Troponin levels were 1 to 3 to 3.7 to 12.4 to 9.04 to 14.0 to 7.8. On 14 days post vaccination, laboratory results included: Brain Natriuretic Peptide-B type 166, C Reactive Protein 2.4. The patient was discharged from the hospital on day 14 post vaccination after Troponin I levels decreased with no further chest pain or ECG changes. Follow-up appointment on day 15 post vaccination patient had no complaints, no fever and no signs or symptoms. He was treated with IBUPROFEN for one month. On 35 days post vaccination, "extensive labs were completed to discover an alternative cause for diagnosis." The only notable result was for a + Dengue IgG, which is of unclear significance given his negative IgM. The patient's final diagnosis was vaccine related myocarditis. The outcome was not reported. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Body temperature fluctuation, Cardiac enzymes increased, Chest X-ray normal, Chest pain, Computerised tomogram normal
Clinical narrative: This case was received on 27 May 2011 from MILVAX under MILVAX tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 a ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59). Treatment medications included: ZOFRAN, TORADOL, ASA, Nitropaste, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Cough, Dyspnoea, Electrocardiogram normal, Fibrin D dimer, Myocarditis
Clinical narrative: This case was received on 27 May 2011 from MILVAX under MILVAX tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 a ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59). Treatment medications included: ZOFRAN, TORADOL, ASA, Nitropaste, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Pericarditis, Troponin I increased
Clinical narrative: This case was received on 27 May 2011 from MILVAX under MILVAX tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 a ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59). Treatment medications included: ZOFRAN, TORADOL, ASA, Nitropaste, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Body temperature fluctuation, Cardiac enzymes increased, Chest X-ray normal, Chest pain, Computerised tomogram thorax normal
Clinical narrative: This case was received on 27 May 2011 from MILVAX under MILVAX tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 a ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59). Treatment medications included: ZOFRAN, TORADOL, ASA, Nitropaste, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Cough, Dyspnoea, Electrocardiogram normal, Fibrin D dimer increased, Myocarditis
Clinical narrative: This case was received on 27 May 2011 from MILVAX under MILVAX tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 a ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59). Treatment medications included: ZOFRAN, TORADOL, ASA, Nitropaste, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Painful respiration, Pericarditis, Troponin I increased
Clinical narrative: This case was received on 27 May 2011 from MILVAX under MILVAX tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 a ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59). Treatment medications included: ZOFRAN, TORADOL, ASA, Nitropaste, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Acute myocardial infarction, Echocardiogram, Electrocardiogram normal, Pericardial disease, Troponin I increased
Clinical narrative: This case was received on 27 May 2011 from MILVAX under MILVAX tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 a ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59). Treatment medications included: ZOFRAN, TORADOL, ASA, Nitropaste, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. Note: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Age: 2.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site reaction, Injection site urticaria, Muscle mass, Rash erythematous
Clinical narrative: Muscle "knot" 2 days out from vaccination (improved with massage). Red "spots" -> hives at injection site 6-7 days after vaccination. Tx prescribed: BENADRYL.
Age: 66.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pruritus generalised
Clinical narrative: Still having redness, swelling and soreness at injection site. Has itching all over body.
Age: 1.05
Sex: M
Vaccine: HIBV, MMR, PNC13, VARCEL
Symptoms: Body temperature increased, Febrile convulsion
Clinical narrative: 5/25/11 at 0500 - temp: 103 F. Febrile seizure. Evaluated at ER. No cough, no rhinorrhea since D/C from ER, playful without seizure activity. Pt eating well, no cough, no rhinorrhea last fever 5/26/2011 temp: 100.5 F.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Local reaction, Pruritus, Tenderness
Clinical narrative: 11cm x 12cm swelling/redness at shot site. Mom applied ice intermittently. No SOB, some tenderness and itching. Reaction appears localized. In office told to take oral BENADRYL and topical hydrocortisone BID PRN reaction was noticed 72 hrs after immunization.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Erythema, Oedema peripheral
Clinical narrative: (L) arm with redness, swelling, decreased possible future "abcess formation" as noted per child's PCP. Symptoms began 5/27/11, being treated with KENALOG & BENADRYL & is improving.
Age: 26.0
Sex: F
Vaccine: MMR
Symptoms: Hot flush, Rash morbilliform
Clinical narrative: Measles like rash with hot flashes, persisting now, going on 2 weeks. Vaccination date 5/11/11, had 1 MMR as a child.
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Injection site rash, Irritability, Rash, Rash papular, Skin warm
Clinical narrative: Rash onset 5/27 am, both legs, scrotum, trunk, pt fussy, rash warm to touch, afebrile. Rash papular in appearance.
Age: 1.12
Sex: F
Vaccine: MMR
Symptoms: Rash generalised
Clinical narrative: Rash on body.
Age: 11.0
Sex: F
Vaccine: RAB
Symptoms: Unevaluable event
Clinical narrative: Pt bitten by dog in (L) hand Sunday 5/15/11.
Age: 41.0
Sex: M
Vaccine: ANTH
Symptoms: Immediate post-injection reaction, Rash, Rash erythematous, Rash pruritic
Clinical narrative: Small red bumps on front & back of trunk, (L)/(R) arms and (R)/(L) legs. No pus oozing. Pt states the bumps are itchy and started appearing Fri after receiving shots on Tue 17 May 11.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MEN, HEPA, HPV4, MNQ
Symptoms: Dizziness, Electrocardiogram normal, Loss of consciousness, Unresponsive to stimuli
Clinical narrative: < 5 mins after received Hep A #2, HPV #2, MCV #1, pt c/o dizziness and became unresponsive slumped in chair. LOC about 30 secs, briefly awoke, then 2nd LOC x few seconds.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MEN, HEPA, HPV4, MNQ
Symptoms: Hypotension, Syncope
Clinical narrative: < 5 mins after received Hep A #2, HPV #2, MCV #1, pt c/o dizziness and became unresponsive slumped in chair. LOC about 30 secs, briefly awoke, then 2nd LOC x few seconds.
Age: 14.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Convulsion, Dyskinesia, Electroencephalogram, Urinary incontinence
Clinical narrative: Pt. given HPV and TDAP. Approx 30 sec. later nurse called to exam room by pt's mother and saw seizure like reaction. Hands flexed and urinary incontinence. Present - non postictal. Referred to doctor - advised no further HPV vac.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Chest pain, Crying, Emotional disorder, Rash, Rash erythematous
Clinical narrative: Rash. Red pinpoint rash on shoulder upper chest and back. Rash occurred within 10-15 minutes of below immunizations. Chest pain - 10-15 minutes after immunizations never any shortness of breath. Pt was very upset crying after administration of vaccines.
Age: 10.0
Sex: M
Vaccine: MMR
Symptoms: Anaphylactic reaction, Cough, Dyspnoea, Lip oedema, Localised oedema
Clinical narrative: Patient received MMR #2 on 5-26-11 at 1:00pm. Mom states patient started sneezing repeatedly at 1:45pm, after leaving the office. Mom states EMS activated, EPIPEN administered & BENADRYL given at 2:00pm due to s/s of anaphyl. widespread hives, SOB, cough, (R) ear, lip edema.
Age: 10.0
Sex: M
Vaccine: MMR
Symptoms: Sneezing, Urticaria
Clinical narrative: Patient received MMR #2 on 5-26-11 at 1:00pm. Mom states patient started sneezing repeatedly at 1:45pm, after leaving the office. Mom states EMS activated, EPIPEN administered & BENADRYL given at 2:00pm due to s/s of anaphyl. widespread hives, SOB, cough, (R) ear, lip edema.
Age: 5.0
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Abdominal pain upper, Malaise, Pyrexia
Clinical narrative: Epigastric pain, fever, malaise -> started w/in hrs of receiving vaccine. Improving slowly but persistent to day 5.
Age: 61.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Pain, Skin warm, Tenderness
Clinical narrative: 5/26/11 -> mild soreness. 5/31/11 -> increased soreness, tender to touch. 6/2/11 -> increased soreness, redness, increased hot to touch. 6/3/11 -> increased in size to 4" x 4" with increased pain, redness & warmth.
Age: 60.0
Sex: F
Vaccine: TTOX
Symptoms: Impaired driving ability, Impaired work ability, Joint range of motion decreased, Mobility decreased, Pain in extremity
Clinical narrative: Soreness onset about 10 hr. post. By 24 hr. (R) arm immobile due to extreme pain. Returned to ER for injection of anti-inflammatory and arm sling. Pt. unable to work or drive. Now taking Hydrocodone 10/325 and P.T. for range of motion in shoulder. Minimal improvement as of 6/1/11.
Age: 60.0
Sex: F
Vaccine: TTOX
Symptoms: X-ray normal
Clinical narrative: Soreness onset about 10 hr. post. By 24 hr. (R) arm immobile due to extreme pain. Returned to ER for injection of anti-inflammatory and arm sling. Pt. unable to work or drive. Now taking Hydrocodone 10/325 and P.T. for range of motion in shoulder. Minimal improvement as of 6/1/11.
Age: 61.0
Sex: U
Vaccine: VARZOS
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Redness, swelling, itching. Given on 5-23-11 at 2:41 p.m.
Age: 1.01
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Erythema, Injection site erythema, Injection site swelling, Local reaction
Clinical narrative: Localized redness and swelling to right arm at injection site. Redness to left arm and leg, which improved after bandaid removal. 1 tsp of BENADRYL given PO per MD order. Recheck reaction at 10:46 AM symptoms improving patient smiling and laughing, patient went home.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Local reaction, Urticaria
Clinical narrative: Hives - generalized & then local reaction to (R) thigh - 12.5mg BENADRYL given & discuss with allergist.
Age: 2.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Redness, swelling of (L) upper arm; about 2.5" x 2.5" surrounding the point of injection. (+) warmth, non tender, no induration.
Age: 2.0
Sex: M
Vaccine: PNC13
Symptoms: Dysarthria, Gait disturbance, Muscular weakness, Pyrexia
Clinical narrative: Fever > 103 degrees x 3-4 days. Slurred speech, abnormal "drunken" gait, weakness on left lower extremity.
Age: 47.0
Sex: F
Vaccine: JEV
Symptoms: Headache, Hearing impaired, Tinnitus
Clinical narrative: Sx's: Headaches, tinnitus, distortion of hearing ranges. Vaccination: 2nd dose 3/24/2011.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Hypersensitivity, Injection site swelling, Syncope
Clinical narrative: On the date of vaccines given child was at check out window and fainted. O2 level checked 98% Heart Rate 45 Blood Pressure 88/44 - rested O2 100% HR 72 patient sent home with mom. 6/2/11 patient with swelling of left thigh allergic reaction.
Age: 73.0
Sex: M
Vaccine: FLU3
Symptoms: Hypoaesthesia, Injection site reaction, Sensory disturbance, Skin reaction
Clinical narrative: Client called facility on 5/5/11 stating complaints of "funny sensation and numbness down left arm, states area where shot was given appears like burned skin patch about 1/4" in diameter."
Age: 10.0
Sex: M
Vaccine: HEP
Symptoms: Alopecia areata
Clinical narrative: Alopecia Areata
Age: 75.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Myalgia
Clinical narrative: Muscle pain, redness, swelling at injection site
Age: 1.25
Sex: F
Vaccine: HEPA, HIBV, MMR, VARCEL
Symptoms: Chest X-ray normal, Febrile convulsion, Metabolic function test normal, Streptococcus test negative, Urine analysis normal
Clinical narrative: Pt had febrile seizure and presented to ER;
Age: 1.25
Sex: F
Vaccine: HEPA, HIBV, MMR, VARCEL
Symptoms: White blood cell count
Clinical narrative: Pt had febrile seizure and presented to ER;
Age: 18.0
Sex: M
Vaccine: MMR, MNQ
Symptoms: Head injury, Hyperhidrosis, Pallor, Syncope
Clinical narrative: Client fainted after leaving the clinic area.  He had received MMR, Menactra, and a TB test.  He was already conscious when I reached him. A witness said he fainted and his his head on a door.  He was pale, and sweating. No injury noted to his head.  Applied ice to his head and took his vital signs.  911 called.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Asthenia, Pain in extremity
Clinical narrative: MINOR C/O INITIAL ARM PAIN STARTING IN THE PM, THEN WOKE UP IN AM 6/03/2011 WITH C/O ENTIRE DAY OF WHOLE BODY WEAKNESS, WORSE UPPER EXTREMITY, RESOLVED 6/04/2011 STATES WAS BETTER ONCE ARM PAIN RESOLVED
Age: 0.46
Sex: M
Vaccine: DTAPHEPBIP, HIBV
Symptoms: Loss of consciousness, Unresponsive to stimuli, Vomiting
Clinical narrative: Left the Dr office right after immunization shots Pediarix & Pedvax. My son passed out, then started throwing up a lot as he was sleeping. He became unconscious and unresponsive. My hubsand, and my father could not wake him up or get him to respond. He was still breathing but we rushed him to the ER. He was unconscious for about 20 minutes.
Age: 30.0
Sex: M
Vaccine: MNQ, TDAP, TYP
Symptoms: Erythema, Pyrexia, Urticaria
Clinical narrative: Redness on chest and slight fever per pt. (URTICARIA) per doctor.
Age: 14.0
Sex: M
Vaccine: HPV4, HPV4
Symptoms: Adverse event, Pruritus
Clinical narrative: THE MOTHER DESCRIBE THAT REACTION WAS A ITCH IN THE SKIN. THE MOTHER OF THE CHILD USE BENADRYL FOR TREAT THE ITCH. THE ADVERSE EVENT DISAPEAR IN AN HOUR.
Age: 14.0
Sex: M
Vaccine: HPV4, HPV4
Symptoms: Dermatitis allergic, Rash
Clinical narrative: THE MOTHER DESCRIBE THAT REACTION WAS A ITCH IN THE SKIN. THE MOTHER OF THE CHILD USE BENADRYL FOR TREAT THE ITCH. THE ADVERSE EVENT DISAPEAR IN AN HOUR.
Age: 1.27
Sex: M
Vaccine: DTAP, HIBV, VARCEL
Symptoms: Rash generalised, Rash pruritic
Clinical narrative: On 5/25 mom noticed a few itchy bumps on patient's neck.  by 5/26 patient had >25 bumps all over body.  Pt's mom was given the following recommendations by phone:  cut patient's fingernails and use oatmeal baths.  Pt's rash worsened over the following several days and he was seen in urgent care on 5/31.
Age: 44.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site discharge, Pain in extremity, Paraesthesia, Scab
Clinical narrative: right arm felt achy and tingly; two previous anthrax injection site began to weep a watery discharge, stopped by next moring, leaving two scabs
Age: 30.0
Sex: F
Vaccine: HEP
Symptoms: Arthralgia, Blood gases, Chest X-ray, Dyspnoea, Electrocardiogram
Clinical narrative: Several hours after shot developed pain in both ankles, swelling in both legs and feet and itching all over.  Reported above to OBI nurse on 6/8/2011 at 11:30 AM. No rash on body but still itching all over.  12:30PM developed difficulty breathing.  Taken to Medical Center by car.  Physician is treating subject for possible pulmonary embolus.  Lungs were clear per ER physician.  3:30 PM Subject still itching all over.  ER Physican unsure if symptoms from vaccination.
Age: 30.0
Sex: F
Vaccine: HEP
Symptoms: Oedema peripheral, Pruritus generalised
Clinical narrative: Several hours after shot developed pain in both ankles, swelling in both legs and feet and itching all over.  Reported above to OBI nurse on 6/8/2011 at 11:30 AM. No rash on body but still itching all over.  12:30PM developed difficulty breathing.  Taken to Medical Center by car.  Physician is treating subject for possible pulmonary embolus.  Lungs were clear per ER physician.  3:30 PM Subject still itching all over.  ER Physican unsure if symptoms from vaccination.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Rash generalised
Clinical narrative: rash over body
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Pyrexia
Clinical narrative: SEVERE FEVER 104
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Redness, swelling, pain at injection site. Redness and swelling by early morning 5" X 2".
Age: 0.77
Sex: M
Vaccine: PNC
Symptoms: Injection site erythema, Injection site swelling, Irritability
Clinical narrative: Quarter-sized red, raised area around injection site. Fussiness. Treated with 1.25ml dose of infants' concentrated ibuprofen.
Age: 0.53
Sex: M
Vaccine: DTAPIPVHIB, HEP
Symptoms: Incorrect dose administered
Clinical narrative: Wrong dose administered to child.  Patient received an adult dose of Hepatitis B instead of infant dose. Vaccine administered: Engerix B Lot# ahbvb986aa  exp: 7/13/2013
Age: 0.34
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Crying, Insomnia, Irritability
Clinical narrative: Intense crying and irritability for 3wks, didn't sleep well at all
Age: 0.42
Sex: M
Vaccine: PNC
Symptoms: Crying, Insomnia
Clinical narrative: Intense crying at night, didn't sleep well at all for at least 1 wk
Age: 1.0
Sex: M
Vaccine: MMR, PNC13, VARCEL
Symptoms: Nonspecific reaction, Rash, Rash macular, Rash papular, Skin plaque
Clinical narrative: 5/15/11 - onset of rash, small red papules on neck. 5/17/11 - rash developed into much larger coalescing raised red macules and plaques on face, arms, legs, spares trunk, back. No fever, no itchy. Pt acting well & normal.
Age: 14.0
Sex: M
Vaccine: HEPA
Symptoms: Headache, Injection site pain, Vomiting
Clinical narrative: C/O vomit/headache w/i 12 hours of injection; vomiting x 1 qd. (L) arm pain at inj site increased to incl upper arm. No redness/swelling at inj site; afebrile. Ice/heat & ibuprofen. PHENERGAN for vomit sx, fluids, TYL or MOTRIN.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP
Symptoms: Muscle rigidity, Pallor, Unresponsive to stimuli
Clinical narrative: Vaccines given at 9:10. Pt did great. As he & parent were driving out of parking lot he became pale, rigid & unresponsive for 10-20 seconds. Pt monitored for 90 minutes then sent home in stable condition.
Age: 29.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Erythema, Joint range of motion decreased, Oedema peripheral, Pain in extremity, Pyrexia
Clinical narrative: Received 2 vaccines 6/2/11 PNEUMOVAX RA, Tdap LA. Per pt fever 6/4/11 to 102 F-103 F, swelling, pain, warmth, redness RA. Eval 6/6/11 by MD. Started on methoxazole (allergy to PCN, clindamycin) 1 tab BID x 10 days. Area of redness marked. Eval 6/7/11 for increased redness & warmth beyond markings with limited ROM of Right arm. Only 3 doses of antibiotics at this time.
Age: 29.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Skin warm
Clinical narrative: Received 2 vaccines 6/2/11 PNEUMOVAX RA, Tdap LA. Per pt fever 6/4/11 to 102 F-103 F, swelling, pain, warmth, redness RA. Eval 6/6/11 by MD. Started on methoxazole (allergy to PCN, clindamycin) 1 tab BID x 10 days. Area of redness marked. Eval 6/7/11 for increased redness & warmth beyond markings with limited ROM of Right arm. Only 3 doses of antibiotics at this time.
Age: 13.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Convulsion, Immediate post-injection reaction, Pallor, Syncope
Clinical narrative: Pt. experienced syncopal episode with mild seizure activity lasting less than 5 seconds immediately after receiving 4 immunizations, no loss of consciousness. Alert and oriented x3. Moving all extremities x4. B/p 140/90/pulse 80/respirations even and unlabored, color slightly pale. Within 15 minutes, client appeared recovered. B/P 120/82/pulse 72, respirations even and unlabored, color pink. Client denied any chest pain/tightness through episode. Able to walk out of Clinic accompanied by Mother. Mother and client counseled to advise future healthcare providers of syncopal hx. prior to any venipunctures or vaccinations.
Age: 12.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Cellulitis, Chills, Erythema, Induration, Injection site mass
Clinical narrative: Pt's left upper arm had a bump the size of a quarter in the morning of 06-07-11. Later that day the swelling became the size of a tennis ball, it also was red, warm and hard. Mom applied a cold compress. Pt also was having chills and body aches on 06-07-11. Pt came into Dr. office on 06-08-11 and she prescribed sulfamethoxazole for cellulitis.
Age: 12.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Pain, Skin warm, Swelling
Clinical narrative: Pt's left upper arm had a bump the size of a quarter in the morning of 06-07-11. Later that day the swelling became the size of a tennis ball, it also was red, warm and hard. Mom applied a cold compress. Pt also was having chills and body aches on 06-07-11. Pt came into Dr. office on 06-08-11 and she prescribed sulfamethoxazole for cellulitis.
Age: 28.0
Sex: F
Vaccine: HEPAB, TYP, YF
Symptoms: Abdominal pain, Headache, Nausea, Pyrexia, Vomiting
Clinical narrative: 20 hrs. after first dose of oral typhoid c/o headache, severe nausea, some vomiting, abd. cramping, fever 100-101 degrees lasting about 12 hrs. Called hotline at the hospital. Was told symptoms normal. Continue taking last pills which she did. Not dehydrated.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Erythema, Eye swelling, Fatigue, Headache
Clinical narrative: Headache 2-3 days post vaccine till current, joint pain, fatigue, rash on face at hairline. Bilateral red streaks on arm, inner leg and foot, rash and swollen fingers both hands, swollen eyes "hive" bump over right eye. Doctor gave steroids.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Oedema peripheral, Rash, Urticaria
Clinical narrative: Headache 2-3 days post vaccine till current, joint pain, fatigue, rash on face at hairline. Bilateral red streaks on arm, inner leg and foot, rash and swollen fingers both hands, swollen eyes "hive" bump over right eye. Doctor gave steroids.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Wound
Clinical narrative: Right thigh - red area 5-6 cm diam. w/2 puncture points, received KINRIX & VARIVAX on 6/7/11, area is red, warm to touch & painful. Tx: warm compress & TYLENOL, F/u PRN.
Age: 1.38
Sex: M
Vaccine: DTAP
Symptoms: Urticaria
Clinical narrative: Hives - treated w BENADRYL.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Rash
Clinical narrative: Rash on abdomen & chest. Patient took 50mg BENADRYL PO on 06/07/11 at onset of symptoms. Patient came in for a 1mL steroid inj and 25ml of Diphenhydramine injection on 06/08/11 at 10:30am.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site discolouration, Injection site induration
Clinical narrative: Indurated slightly darkened area surrounding injection site.
Age: 0.68
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC13, RV5
Symptoms: Barium enema, Intussusception
Clinical narrative: Intussusception 6/4/1011.
Age: 2.0
Sex: F
Vaccine: MMR
Symptoms: Exposure to toxic agent, Full blood count, Idiopathic thrombocytopenic purpura, Nasopharyngitis, Platelet count decreased
Clinical narrative: The child had vomiting within hours of admin. Had fever assoc with cold in 1 wk. Developed I.T.P. within 2 weeks (5/25/11). She also was exposed to pesticides during this time.
Age: 2.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Vomiting
Clinical narrative: The child had vomiting within hours of admin. Had fever assoc with cold in 1 wk. Developed I.T.P. within 2 weeks (5/25/11). She also was exposed to pesticides during this time.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: 48h after MMRV & DTaP developed swollen deltoid, red & warmth 15 x 12 cm.
Age: 13.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Induration
Clinical narrative: 10 x 11 cm induration, erythema left arm.
Age: 31.0
Sex: F
Vaccine: TDAP
Symptoms: Neck pain, Rash pruritic
Clinical narrative: Approx 1 hour after vaccination, patient reported pain on left side of neck, next to trachea. Later in evening, she developed an itchy rash under both armpits. Still symptomatic today. Advised hydrocortisone cream &/or P.O. antihistamines for itching. Advised follow-up with physician if symptoms worsen. Still has symptoms at this time.
Age: 0.77
Sex: F
Vaccine: HEP
Symptoms: Rash papular
Clinical narrative: Rec'd Hep B 6/2/11 on 6/5/11 early am, noted to have 3 papule on (R) wrist. No temp, no somatic sxs. Exam on 6/8/11 reflects likely contact rash.
Age: 37.0
Sex: F
Vaccine: TDAP
Symptoms: Fatigue, Headache, Injection site induration, Injection site pain, Injection site reaction
Clinical narrative: Left arm injection site swelling, induration 1. 5" tender, erythematous rash, with mild tingling (L) upper extremity, headache and tiredness x 3 days. Cold compress, OTC NSAIDS. Raise extremity on pillow. Go to ER with symptom worsening.
Age: 37.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site swelling, Joint range of motion decreased, Paraesthesia, Rash erythematous
Clinical narrative: Left arm injection site swelling, induration 1. 5" tender, erythematous rash, with mild tingling (L) upper extremity, headache and tiredness x 3 days. Cold compress, OTC NSAIDS. Raise extremity on pillow. Go to ER with symptom worsening.
Age: 18.0
Sex: M
Vaccine: HEPA, HPV4, IPV, MNQ, TDAP, VARCEL
Symptoms: Back pain, Cold sweat, Dizziness, Gait disturbance, Headache
Clinical narrative: At 0938 client c/o H/A, back, neck pain and dizziness. He was clammy. R-18, P-80, at 0940 P-84, BP 70/40, states feeling worse, called 911, at 0943 BP 80/64, P80, drowsy mother at side, at 0946 EMT here transport to Hospital with mother. Client able to walk out (unsteady gait).
Age: 18.0
Sex: M
Vaccine: HEPA, HPV4, IPV, MNQ, TDAP, VARCEL
Symptoms: Neck pain, Somnolence
Clinical narrative: At 0938 client c/o H/A, back, neck pain and dizziness. He was clammy. R-18, P-80, at 0940 P-84, BP 70/40, states feeling worse, called 911, at 0943 BP 80/64, P80, drowsy mother at side, at 0946 EMT here transport to Hospital with mother. Client able to walk out (unsteady gait).
Age: 1.0
Sex: F
Vaccine: HIBV, MMR, PNC13, VARCEL
Symptoms: Diarrhoea, Irritability, Somnolence, Vomiting
Clinical narrative: 1 y female for WCC, received PCV 13, Hib, MMR, Varicella. Sleepy, fussy after admin. Then next AM vomiting and diarrhea x 3 . No fever, 24 hrs later better.
Age: 8.0
Sex: M
Vaccine: TD
Symptoms: Injection site rash, Rash generalised
Clinical narrative: Broke out in a rash around TD area and entire body yesterday at 6:00pm came in our office 11:30 AM 6/8/11. Td site 34x20 mm BENADRYL 25mg 1-6hrs for 7 days.
Age: 8.0
Sex: M
Vaccine: TYP
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fever and severe fatigue
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Pericarditis
Clinical narrative: Pericarditis manifested by chest pain
Age: 40.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site cellulitis
Clinical narrative: cellulitis at injection site